Form 4: Robert Kraft, Medpace Holdings Director, Reports Stock Unit Vesting
SEC Form 4 Filing
Director Robert Kraft reports the vesting of restricted stock units in Medpace Holdings, Inc.
Summary
- Robert Kraft, a director of Medpace Holdings, Inc. (MEDP), reported the vesting of 57 restricted stock units on March 31, 2025.
- These units are part of a grant of 227 restricted stock units awarded on November 29, 2024, vesting in four equal installments.
- Each restricted stock unit represents the right to receive one share of MEDP common stock.
- Following the transaction, Kraft directly owns 170 derivative securities.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a standard disclosure of stock unit vesting, which is part of pre-arranged compensation.
Industry Context
This filing is a routine disclosure related to insider transactions and is a standard part of regulatory compliance for publicly traded companies. It provides transparency regarding the holdings and transactions of company insiders.
Stakeholder Impact
- The vesting of restricted stock units has a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| November 29, 2024 | Reporting Person was granted 227 restricted stock units |
| March 31, 2025 | Vesting of 57 restricted stock units |
| June 30, 2025 | Next vesting date for restricted stock units |
| September 30, 2025 | Next vesting date for restricted stock units |
| December 31, 2025 | Final vesting date for restricted stock units |
| April 02, 2025 | Date of Form 4 filing |
Keywords
Medpace Holdings, Robert Kraft, restricted stock units, Form 4, insider trading, vesting, MEDP, director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.